Shi HY - Search Results

1

Antibiotic usage in Chinese children: a point prevalence survey.

Zhang JS, Liu G, Zhang WS, Shi HY, Lu G, Zhao CA, Li CC, Li YQ, Shao YN, Tian DY, Ding MJ, Li CY, Luo LJ, Dong XY, Jin P, Wang P, Zhu CM, Wang CQ, Zheng YJ, Deng JK, Sharland M, Hsia YF, Shen KL, Yang YH. Zhang JS, et al. Among authors: shi hy. World J Pediatr. 2018 Aug;14(4):335-343. doi: 10.1007/s12519-018-0176-0. Epub 2018 Jul 30. World J Pediatr. 2018. PMID: 30062648

2

Cefotiam Treatment in Children: Evidence of Subtherapeutic Levels.

Kan M, Wu L, Zhou XW, Jiang YF, Wu YE, Shi HY, Hao GX, Zheng Y, Su LQ, Huang X, Zhao W. Kan M, et al. Among authors: shi hy. Ther Drug Monit. 2020 Oct;42(5):733-736. doi: 10.1097/FTD.0000000000000759. Ther Drug Monit. 2020. PMID: 32251152

3

Spectrum-Effect Relationship Between Antioxidant and Anti-inflammatory Effects of Banxia Baizhu Tianma Decoction: An Identification Method of Active Substances With Endothelial Cell Protective Effect.

Xu N, Li M, Wang P, Wang S, Shi H. Xu N, et al. Front Pharmacol. 2022 Jan 24;13:823341. doi: 10.3389/fphar.2022.823341. eCollection 2022. Front Pharmacol. 2022. PMID: 35140620 Free PMC article.

4

Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants.

Qi H, Kou C, Qi YJ, Tang BH, Wu YE, Jin F, Luo XJ, Shen YH, Guo YJ, Qi X, Wang YC, Dong Q, Chen XK, Shi HY, Zheng Y, Zhao W, Shen AD. Qi H, et al. Among authors: shi hy. Int J Antimicrob Agents. 2019 Mar;53(3):347-351. doi: 10.1016/j.ijantimicag.2018.11.017. Epub 2018 Nov 22. Int J Antimicrob Agents. 2019. PMID: 30472290

5

Developmental population pharmacokinetics-pharmacodynamics and dosing optimization of cefoperazone in children.

Shi HY, Wang K, Wang RH, Wu YE, Tang BH, Li X, Du B, Kan M, Zheng Y, Xu BP, Shen AD, Su LQ, Jacqz-Aigrain E, Huang X, Zhao W. Shi HY, et al. J Antimicrob Chemother. 2020 Jul 1;75(7):1917-1924. doi: 10.1093/jac/dkaa071. J Antimicrob Chemother. 2020. PMID: 32129861

6

Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic Analysis.

Wang YK, Wu YE, Li X, Tian LY, Khan MW, Tang BH, Shi HY, Zheng Y, Hao GX, van den Anker J, You DP, Zhao W. Wang YK, et al. Among authors: shi hy. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01412-20. doi: 10.1128/AAC.01412-20. Print 2020 Oct 20. Antimicrob Agents Chemother. 2020. PMID: 32816735 Free PMC article.

7

Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study.

Wu YE, Wang T, Yang HL, Tang BH, Kong L, Li X, Gao Q, Li X, Yao BF, Shi HY, Huang X, Wang WQ, Jacqz-Aigrain E, Allegaert K, van den Anker J, Tian XY, Zhao W. Wu YE, et al. Among authors: shi hy. J Antimicrob Chemother. 2021 Feb 11;76(3):699-709. doi: 10.1093/jac/dkaa468. J Antimicrob Chemother. 2021. PMID: 33188385 Clinical Trial.

8

Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.

Li X, Qi H, Jin F, Yao BF, Wu YE, Qi YJ, Kou C, Wu XR, Luo XJ, Shen YH, Zheng X, Wang YH, Xu F, Jiao WW, Li JQ, Xiao J, Dong YN, Du B, Shi HY, Xu BP, Shen AD, Zhao W. Li X, et al. Among authors: shi hy. Eur J Pharm Sci. 2021 Aug 1;163:105868. doi: 10.1016/j.ejps.2021.105868. Epub 2021 May 2. Eur J Pharm Sci. 2021. PMID: 33951483

9

Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia.

Zheng Y, Liu SP, Xu BP, Shi ZR, Wang K, Yang JB, Huang X, Tang BH, Chen XK, Shi HY, Zhou Y, Wu YE, Qi H, Jacqz-Aigrain E, Shen AD, Zhao W. Zheng Y, et al. Among authors: shi zr, shi hy. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00686-18. doi: 10.1128/AAC.00686-18. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 29941652 Free PMC article.

10

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children.

Li Q, Wang K, Shi HY, Wu YE, Zhou Y, Kan M, Zheng Y, Hao GX, Yang XM, Yang YL, Su LQ, Wang XL, Jacqz-Aigrain E, Zhou J, Zhao W. Li Q, et al. Among authors: shi hy. Drug Des Devel Ther. 2019 Dec 27;13:4405-4411. doi: 10.2147/DDDT.S226913. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31920289 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

486 results

Search Page

Filters